Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.7M Sell
52,372
-10,296
-16% -$4.75M 0.2% 26
2026
Q1
$30.1M Sell
62,668
-19,899
-24% -$10.2M 0.23% 20
2025
Q4
$46.4M Sell
82,567
-44,970
-35% -$25.5M 0.27% 34
2025
Q3
$65.6M Hold
127,537
0.33% 32
2025
Q2
$40M Hold
127,537
0.17% 36
2025
Q1
$38.9M Hold
127,537
0.18% 37
2024
Q4
$42.4M Buy
+127,537
New +$43.3M 0.18% 35

Other funds holding MEDP

Terry Smith's MEDP Position: Q2 2026 in Review

Terry Smith reduced its Medpace (MEDP) stake by 16% in Q2 2026, selling an estimated $4.75M and leaving 52,372 shares worth $27.7M. The position accounts for 0.2% of the portfolio, ranked #26.

Terry Smith first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $65.6M in Q3 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Terry Smith held 52,372 shares of Medpace worth $27.7M as of Q2 2026.
  • Terry Smith sold 10,296 Medpace shares in Q2 2026, an estimated $4.75M.
  • Medpace made up 0.2% of Terry Smith's portfolio in Q2 2026, its #26 holding.
  • Terry Smith first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Terry Smith's Medpace position peaked at $65.6M in Q3 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Fundsmith LLP's 13F filing for Q2 2026, filed 14 Aug 2026.